Based on the available literature and considering that this is a structural marker, the authors believe that NGAL has potential as an additional biomarker for kidney disease (including its possibility to detect AKI earlier than creatinine), but also potential as a marker of inflammation. The gene discussed is LCN2; the disease is kidney disorder.